The 1000-fold induction of acute phase serum amyloid A (A-SAA) in the
liver during inflammation indicates that this protein plays an importa
nt, though ill-defined, role in host defence, Paradoxically, prolonged
overproduction of A-SAA is a causative factor in secondary amyloidosi
s and possibly other diseases such as atherosclerosis; the ability to
down-regulate A-SAA synthesis is therefore of considerable clinical im
portance, We have successfully generated anti-SAA hammerhead ribozymes
and we report that they are capable of cleaving A-SAA mRNA in vitro.